Kader, Avan; Brangsch, Julia; Kaufmann, Jan O.; Zhao, Jing; Mangarova, Dilyana B.; Moeckel, Jana; Adams, Lisa C.; Sack, Ingolf; Taupitz, Matthias; Hamm, Bernd; Makowski, Marcus R.
Year of publication:
This review summarizes recent developments regarding molecular imaging markers for magnetic resonance imaging (MRI) of prostate cancer (PCa). Currently, the clinical standard includes MR imaging using unspecific gadolinium-based contrast agents. Specific molecular probes for the diagnosis of PCa could improve the molecular characterization of the tumor in a non-invasive examination. Furthermore, molecular probes could enable targeted therapies to suppress tumor growth or reduce the tumor size.